- Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
-
Iwamoto H, Shimose S, Niizeki T, Koga H, Torimura T, The Kurume Liver Cancer Study Group of Japan
- KMID: 2531380
- Clin Mol Hepatol.
- 2022 Jul;28(3):575-579.
- doi: 10.3350/cmh.2022.0047
-
- CITED
-
- Close
- SHARE
-
- Close
- Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
-
Suzuki H, Shimose S, Iwamoto H, Niizeki T, Kawaguchi T
- KMID: 2554431
- Clin Mol Hepatol.
- 2024 Apr;30(2):263-265.
- doi: 10.3350/cmh.2023.0557
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
-
Koga H, Iwamoto H, Suzuki H, Shimose S, Nakano M, Kawaguchi T
- KMID: 2541403
- Clin Mol Hepatol.
- 2023 Apr;29(2):242-251.
- doi: 10.3350/cmh.2023.0102
Striking advances in systemic therapy for unresectable advanced hepatocellular carcinoma (HCC) have improved the average prognosis of patients with HCC. As a result, the guidelines for the treatment of HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Magnetic Compression Duct-to-duct Anastomosis for Biliary Obstruction in a Patient with Living Donor Liver Transplantation
-
Itoi T, Yamanouchi E, Ikeuchi N, Kasuya K, Iwamoto H, Tsuchida A
- KMID: 2053439
- Gut Liver.
- 2010 Sep;4(Suppl 1):S96-S98.
Magnetic compression anastomosis (MCA) is a minimally invasive method of performing choledochocholedochostomy without surgery in patients with biliary stricture or obstruction. We describe a successful case involving magnetic compression duct-to-duct... -
- CITED
-
- Close
- SHARE
-
- Close
- Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
-
Kadomoto S, Shigehara , Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A
- KMID: 2465418
- World J Mens Health.
- 2020 Jan;38(1):132-136.
- doi: 10.5534/wjmh.180130
We had six cases of patients who were treated with long-term testosterone replacement therapy (TRT) after high dose-rate (HDR) brachytherapy and androgen deprivation therapy for high-risk prostate cancer. All patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
-
Torimura T, Iwamoto H
- KMID: 2514763
- Clin Mol Hepatol.
- 2021 Apr;27(2):236-245.
- doi: 10.3350/cmh.2020.0204
Hepatocellular carcinoma (HCC) is usually accompanied by chronic liver damage, which sometimes influences the selection of HCC treatment. The Barcelona Clinic Liver Cancer (BCLC) staging system, which was first introduced... -
- CITED
-
- Close
- SHARE
-
- Close
